当前位置:首页 - 行情中心 - 德源药业(920735) - 财务分析 - 现金流量表

德源药业

(920735)

  

流通市值:39.22亿  总市值:44.35亿
流通股本:1.04亿   总股本:1.17亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金780,182,348.6494,325,261.84246,429,650.94811,278,048.4
  收到的税费返还3,244,477.673,229,766.95-3,649,201.77
  收到其他与经营活动有关的现金26,758,997.195,526,885.681,337,274.2352,901,636.2
  经营活动现金流入小计810,185,823.46503,081,914.47247,766,925.17867,828,886.37
  购买商品、接受劳务支付的现金109,882,690.9771,056,197.0638,980,557.3687,393,796.69
  支付给职工以及为职工支付的现金139,396,996.1196,966,170.0453,986,562149,923,905.45
  支付的各项税费106,260,030.9677,457,079.6133,500,120.65114,795,413
  支付其他与经营活动有关的现金345,626,363.19228,460,653.08105,743,189.77399,393,750.26
  经营活动现金流出小计701,166,081.23473,940,099.79232,210,429.78751,506,865.4
  经营活动产生的现金流量净额109,019,742.2329,141,814.6815,556,495.39116,322,020.97
二、投资活动产生的现金流量:
  取得投资收益收到的现金4,311,102.792,982,726.1660,544.514,308,845.73
  处置固定资产、无形资产和其他长期资产收回的现金净额8,6129,624.03-34,216.39
  收到的其他与投资活动有关的现金1,402,600,0001,082,600,000341,000,0001,966,800,000
  投资活动现金流入小计1,406,919,714.791,085,592,350.13341,660,544.511,971,143,062.12
  购建固定资产、无形资产和其他长期资产支付的现金27,448,617.8119,122,192.229,200,804.2233,973,866.14
  支付其他与投资活动有关的现金1,661,120,7501,172,798,250482,698,2502,161,955,333.33
  投资活动现金流出小计1,688,569,367.811,191,920,442.22491,899,054.222,195,929,199.47
  投资活动产生的现金流量净额-281,649,653.02-106,328,092.09-150,238,509.71-224,786,137.35
三、筹资活动产生的现金流量:
  取得借款收到的现金---27,090,000
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---27,090,000
  偿还债务支付的现金27,090,00012,590,000-26,500,000
  分配股利、利润或偿付利息支付的现金36,369,020.6336,349,808.13187,339.9928,925,509.55
  支付其他与筹资活动有关的现金901,404--1,202,569.79
  筹资活动现金流出小计64,360,424.6348,939,808.13187,339.9956,628,079.34
  筹资活动产生的现金流量净额-64,360,424.63-48,939,808.13-187,339.99-29,538,079.34
五、现金及现金等价物净增加额-236,990,335.42-126,126,085.54-134,869,354.31-138,002,195.72
  加:期初现金及现金等价物余额303,978,604.29303,978,604.29303,978,604.29441,980,800.01
  期末现金及现金等价物余额66,988,268.87177,852,518.75169,109,249.98303,978,604.29
补充资料:
  净利润-97,785,465-176,983,423.5
  资产减值准备-1,181,992.82--
  固定资产和投资性房地产折旧-13,072,590.29-25,575,664.49
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-13,072,590.29-25,575,664.49
  无形资产摊销-436,750.44-1,500,092.82
  长期待摊费用摊销-159,329.02-121,201.49
  固定资产报废损失-85,121.41-46,697.53
  公允价值变动损失--386,739.73--66,684.93
  财务费用-383,823.25-799,771.22
  投资损失--4,210,615.76--4,739,100.37
  递延所得税--140,446.1--2,762,794.33
  其中:递延所得税资产减少--66,510.42--3,002,309.5
    递延所得税负债增加--73,935.68-239,515.17
  存货的减少--943,905.42--7,671,115.9
  经营性应收项目的减少--102,912,402.98--145,941,362.48
  经营性应付项目的增加-23,334,268.48-70,945,374.75
  其他---725,470.13
  现金的期末余额-177,852,518.75-303,978,604.29
  减:现金的期初余额-303,978,604.29-441,980,800.01
  现金及现金等价物的净增加额--126,126,085.54--138,002,195.72
公告日期2025-10-302025-08-192025-04-282025-03-31
审计意见(境内)标准无保留意见
TOP↑